ari.org.uk
Home
Questions
Organisations
Topics
Research fields
About the data
Viewing all questions
Search
Filter results
Filter results
Select a topic
All topics
ageism
drug rehabilitation
health
health care approach
medical condition
medical research
mental health and disorder
obesity
public health
science and technology
society
Select an organisation
All Organisations
Department for Science, Innovation & Technology
Select a research field
All fields of research
biomedical and clinical sciences
clinical sciences
epidemiology
health sciences
nutrition and dietetics
other health sciences
public health
Select a country
England
Wales
Northern Ireland
Scotland
UK-wide
Clear all filters
Sort
Relevance
Newest first
Oldest first
Question A-Z
Question Z-A
Include archived/expired questions
1-2 of 2 results
Government Office for Life Sciences - Healthcare Missions (Cancer, Ageing, Dementia, Mental Health, Respiratory Disease, Obesity, Vaccines, Addiction)
Evidence on whether reductions in excess adiposity improve patient outcomes and prevent the incidence of developing secondary disease or multiple long-term conditions.
Department for Science, Innovation & Technology, 2024
healthcare
obesity
patient outcomes
long-term conditions
secondary diseases
See details
Government Office for Life Sciences - Healthcare Missions (Cancer, Ageing, Dementia, Mental Health, Respiratory Disease, Obesity, Vaccines, Addiction)
Evidence on the prevalence of long-term conditions associated with the disease areas covered by the healthcare missions (cancer, ageing, dementia, mental health, respiratory disease, obesity, addiction). Further, we would like to understand what links exist between these disease areas: whether there are mutual risk factors or whether any of these disease areas are a risk factor for another.
Department for Science, Innovation & Technology, 2024
healthcare missions
long-term conditions
disease prevalence
risk factors
comorbidity
See details
1